Who Owns PrEP Drugs?: Unpacking a Complex History of Patents and Public Health
•
3 min read
The U.S. government filed a lawsuit against Gilead Sciences in 2019, alleging that the CDC holds key patents related to HIV prevention methods using the active ingredients in branded PrEP drugs. Understanding **who owns PrEP drugs?** is a complex matter involving major pharmaceutical companies, federal agencies, and generic manufacturers all vying for control and market share, with significant implications for public health.